Edward M. Acton

2.0k total citations
72 papers, 1.6k citations indexed

About

Edward M. Acton is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Edward M. Acton has authored 72 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Organic Chemistry, 28 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Edward M. Acton's work include Cancer therapeutics and mechanisms (13 papers), Carbohydrate Chemistry and Synthesis (13 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Edward M. Acton is often cited by papers focused on Cancer therapeutics and mechanisms (13 papers), Carbohydrate Chemistry and Synthesis (13 papers) and Bioactive Compounds and Antitumor Agents (8 papers). Edward M. Acton collaborates with scholars based in United States, Canada and Czechia. Edward M. Acton's co-authors include Leon Goodman, Kenneth J. Ryan, George L. Tong, David W. Henry, Carol W. Mosher, Allan N. Fujiwara, Hsiao-Hsiung Chen, J. William Lown, James A. Plambeck and Richard L. Wolgemuth and has published in prestigious journals such as Nature, Science and Journal of the American Chemical Society.

In The Last Decade

Edward M. Acton

70 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Edward M. Acton United States 25 827 803 377 207 165 72 1.6k
Aristide Vigevani Italy 21 556 0.7× 631 0.8× 264 0.7× 122 0.6× 64 0.4× 82 1.6k
P. Orezzi Italy 12 689 0.8× 411 0.5× 380 1.0× 219 1.1× 81 0.5× 14 1.3k
Cristina Geroni Italy 24 1.0k 1.2× 453 0.6× 508 1.3× 99 0.5× 104 0.6× 76 1.6k
William C. Lumma United States 22 746 0.9× 1.1k 1.4× 159 0.4× 147 0.7× 27 0.2× 62 2.3k
Mary F. Malley United States 29 740 0.9× 2.1k 2.7× 235 0.6× 47 0.2× 42 0.3× 64 3.6k
Fabio Animati Italy 18 600 0.7× 259 0.3× 311 0.8× 168 0.8× 89 0.5× 38 954
J. W. LOWN Canada 16 609 0.7× 485 0.6× 140 0.4× 18 0.1× 152 0.9× 61 1.0k
Bertrand Castro France 29 1.7k 2.0× 1.1k 1.3× 211 0.6× 57 0.3× 24 0.1× 76 2.5k
Nicola Mongelli Italy 26 1.2k 1.5× 822 1.0× 255 0.7× 17 0.1× 54 0.3× 81 2.1k
H. C. J. OTTENHEIJM Netherlands 28 1.9k 2.3× 1.9k 2.3× 222 0.6× 108 0.5× 41 0.2× 121 2.9k

Countries citing papers authored by Edward M. Acton

Since Specialization
Citations

This map shows the geographic impact of Edward M. Acton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edward M. Acton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edward M. Acton more than expected).

Fields of papers citing papers by Edward M. Acton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edward M. Acton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edward M. Acton. The network helps show where Edward M. Acton may publish in the future.

Co-authorship network of co-authors of Edward M. Acton

This figure shows the co-authorship network connecting the top 25 collaborators of Edward M. Acton. A scholar is included among the top collaborators of Edward M. Acton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edward M. Acton. Edward M. Acton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Acton, Edward M.. (2014). Russia.
2.
Acton, Edward M., V. L. Narayanan, Prabhakar Risbood, et al.. (1994). Anticancer Specificity of Some Ellipticinium Salts against Human Brain Tumors in vitro. Journal of Medicinal Chemistry. 37(14). 2185–2189. 107 indexed citations
3.
Stoeckler, Johanna D., et al.. (1990). Inhibition of nucleoside transport by nitrobenzylthioformycin analogs. Biochemical Pharmacology. 40(3). 615–619. 7 indexed citations
4.
Acton, Edward M., et al.. (1986). N-(Cyanomethyl)- and N-(2-methoxy-1-cyanoethyl)anthracyclines and related carboxyl derivatives. Journal of Medicinal Chemistry. 29(10). 2074–2079. 6 indexed citations
5.
Wassermann, Karsten, Leonard A. Zwelling, Lynn Silberman, et al.. (1986). Effects of 3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin and doxorubicin on the survival, DNA integrity, and nucleolar morphology of human leukemia cells in vitro.. PubMed. 46(8). 4041–6. 22 indexed citations
6.
Jensen, Richard A., Edward M. Acton, & John H. Peters. (1984). Electrocardiographic and transmembrane potential effects of 5-iminodaunorubicin in the rat.. PubMed. 44(9). 4030–9. 19 indexed citations
7.
Johnston, James B., et al.. (1983). 3′-(3-cyano-4-morpholinyl)-3′-deaminoadriamycin: A new anthracycline with intense potency. Biochemical Pharmacology. 32(21). 3255–3258. 18 indexed citations
8.
Acton, Edward M. & George L. Tong. (1981). Approaches to phenazine‐derivedN‐isosteres of anthracyclinones. Journal of Heterocyclic Chemistry. 18(6). 1141–1147. 4 indexed citations
9.
10.
Folkers, Karl, et al.. (1978). Inhibition of nucleic acid synthesis in leukemia 1210 cells by antimetabolites of coenzyme Q10. Biochemical and Biophysical Research Communications. 83(2). 353–356. 3 indexed citations
11.
Lee, William W., Helen Y. Wu, Carol W. Mosher, et al.. (1975). Confirmation by synthesis of ristosamine as 3-amino-2,3,6-trideoxy-L-ribo-hexose. Journal of Medicinal Chemistry. 18(7). 767–768. 30 indexed citations
12.
Acton, Edward M., Allan N. Fujiwara, Leon Goodman, & David W. Henry. (1974). Synthetic C-nucleosides: 3-(α- and β-D-arabinofuranosyl)pyrazolo[4,3-d]pyrimidine-5,7-diones. Carbohydrate Research. 33(1). 135–151. 33 indexed citations
13.
Fujiwara, Allan N., Edward M. Acton, & Leon Goodman. (1969). N‐Oxides and S‐oxides of ellipticine analogs. Journal of Heterocyclic Chemistry. 6(3). 389–392. 3 indexed citations
14.
Mosher, Carol W., et al.. (1967). Bishomofolic acid. A new synthesis of folic acid analogs. The Journal of Organic Chemistry. 32(5). 1452–1458. 7 indexed citations
15.
Mosher, Carol W., et al.. (1967). The synthesis of daunosamine. Chemical Communications (London). 973b–973b. 6 indexed citations
16.
Mosher, Carol W., et al.. (1966). Preparation and Antitumor Activity of Olivacine and Some New Analogs1. Journal of Medicinal Chemistry. 9(2). 237–241. 29 indexed citations
17.
Ryan, Kenneth J., Henri Arzoumanian, Edward M. Acton, & Leon Goodman. (1964). Configurational Inversion within a Furanoside Ring by Anchimerically Assisted Displacement: 5-Deoxy-D-ribose from 5-Deoxy-D-xylose. Journal of the American Chemical Society. 86(12). 2497–2503. 24 indexed citations
18.
Ryan, Kenneth J., Henri Arzoumanian, Edward M. Acton, & Leon Goodman. (1964). Synthesis of Homoribose (5-Deoxy-D-allose) and Homoadenosine. Journal of the American Chemical Society. 86(12). 2503–2508. 29 indexed citations
19.
Acton, Edward M., et al.. (1963). 2′-Deoxythioguanosine and its α-Anomer. Nature. 198(4877). 285–285. 3 indexed citations
20.
Cope, Arthur C., et al.. (1957). Proximity Effects. XI. Reaction of trans-1,2-Dibromocycloheptane with Silver Acetate1. Journal of the American Chemical Society. 79(23). 6292–6295. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aristide Vigevani Breakdown of academic impact, for papers by P. Orezzi Breakdown of academic impact, for papers by Cristina Geroni Breakdown of academic impact, for papers by William C. Lumma Breakdown of academic impact, for papers by Mary F. Malley Breakdown of academic impact, for papers by Fabio Animati Breakdown of academic impact, for papers by J. W. LOWN Breakdown of academic impact, for papers by Bertrand Castro Breakdown of academic impact, for papers by Nicola Mongelli Breakdown of academic impact, for papers by H. C. J. OTTENHEIJM
Rankless by CCL
2026